Debeglazid M60 Tablet

Composition of Debeglazid M60 Tablet

Debeglazid M60 Tablet contains Gliclazide modified release 60 mg. It belongs to the Sulfonylurea (second generation) class of medicines.

Uses of Debeglazid M60 Tablet

• Type 2 diabetes mellitus (non-insulin-dependent)
• as an adjunct to diet and exercise to improve glycaemic control

Key benefits

• Lowers blood glucose in type 2 diabetes
• Helps control fasting and postprandial sugar levels
• Once-daily modified-release dosing
• Reduces symptoms of hyperglycaemia
• Supports long-term glycaemic control when combined with diet and exercise

How Debeglazid M60 Tablet works

Gliclazide is a sulfonylurea antidiabetic that stimulates insulin release from pancreatic beta cells by closing ATP-sensitive potassium channels. The modified-release formulation provides prolonged glucose-lowering effect over 24 hours, helping control fasting and post-meal blood sugar.

How to take Debeglazid M60 Tablet

Oral tablet (modified-release). Take once daily with breakfast or the first main meal; swallow whole with water and do not crush/chew/split unless advised. Dose is individualized by the doctor; if a dose is missed, take the next dose at the usual time (do not double).

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Take it as soon as you remember. If your next dose is almost due, skip the one you missed — never take two doses together to catch up.

If you take too much

An overdose of this medicine can cause severe and prolonged low blood sugar, which may lead to fits or unconsciousness. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.

Side effects of Debeglazid M60 Tablet

Most side effects of Debeglazid M60 are mild and settle as the body adjusts. Reported side effects include:

• Hypoglycaemia
• dizziness
• headache
• nausea
• abdominal pain
• diarrhoea
• constipation
• weight gain
• skin rash/itching
• increased liver enzymes

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Debeglazid M60 Tablet

Warnings and precautions

Risk of hypoglycaemia—more likely with missed meals, excess exercise, alcohol intake, elderly patients, or when used with other antidiabetics. Use with caution in kidney or liver impairment; monitor blood glucose and HbA1c regularly. Inform doctor if you have G6PD deficiency (risk of haemolysis), adrenal/pituitary insufficiency, or if you develop fever/infection/trauma (dose adjustment may be needed). Stop and seek care for severe allergic reactions, jaundice, or persistent hypoglycaemia. Not for type 1 diabetes or diabetic ketoacidosis.

Do not take Debeglazid M60 if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Not for type 1 diabetes or for diabetic ketoacidosis. Not for people with severe kidney or liver disease.

Interactions with other medicines

Other antidiabetics/insulin (increased hypoglycaemia risk), fluconazole (increases gliclazide effect), miconazole (avoid; severe hypoglycaemia), macrolide antibiotics, quinolones, sulfonamides, warfarin (may increase anticoagulant effect), beta-blockers (mask hypoglycaemia symptoms), corticosteroids and diuretics (reduce glucose control), ACE inhibitors (may enhance hypoglycaemia), alcohol (increases hypoglycaemia risk)

How to store Debeglazid M60 Tablet

Store below 25°C in a dry place, protected from moisture and light. Keep out of reach of children.

Expert advice for Debeglazid M60 Tablet

Take it shortly before a meal, and eat that meal. Check your sugar as often as your doctor has asked, especially when your routine changes.

Manufacturer and class

Manufacturer:

TAGUS PHARMACEUTICALS

Therapeutic class:

Antidiabetic

Drug class:

Sulfonylurea (second generation)